Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety study of cervical intrathecal baclofen on pulmonary function and sleep-related breathing disorders in spinal cord injury
NL-OMON55571Phase 4Recruiting
- Sponsor
- Roessingh
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of baclofen in Muscle spasm, sponsored by Roessingh. Primary endpoints: Pulmonary function safety, Respiratory function safety and 1 more. Started May 2023; status: recruiting.
02
Drugs
baclofen
03
Conditions
Muscle spasm
Beyond the preview
Go deeper on NL-OMON55571.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON55571.